Mendus granted US patent for use of vididencel in ovarian cancer

What we doOur approachPipelineTechnologyPublicationsPatient and Clinical Perspectives
About usExecutive ManagementBoard of DirectorsScientific Advisory Board
News & eventsPress releasesEventsInterviews
Investors
Careers

Back
Mendus granted US patent for use of vididencel in ovarian cancer
 8:00:00 AM

Keep reading
Invitation to second quarter financial report and business updateRead